Implantable cardioverter defibrillator in high-risk long QT syndrome patients

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 4, 2003, Pages 337-341

  Zareba, Wojciech ^a,b   Moss, Arthur J ^a   Daubert, James P ^a   Hall, W Jackson ^a   Robinson, Jennifer L ^a   Andrews, Mark ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Death sudden; Defibrillation; Long QT syndrome; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARREST; HIGH RISK PATIENT; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; SYNCOPE; TREATMENT INDICATION;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; CHILD; DEFIBRILLATORS, IMPLANTABLE; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; LONG QT SYNDROME; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SYNCOPE; TREATMENT OUTCOME;

EID: 0037623309     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2003.02545.x     Document Type: Article

References (21)

1. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati E, McCluer J, Hall WJ, Weitkemp L, Vincent GM, Garson A, Robinson J, Benhorin J: The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144.
2. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS: Diagnostic criteria for the long QT syndrome. An update. Circulation 1993;88:782-784.
3. Vincent GM, Timothy KW, Leppert M, Keating M: The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 1992;327:846-852.
4. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ: Influence of genotype on the clinical course of the long QT syndrome. N Engl J Med 1998;339:960-965.
5. Zareba W, Moss AJ, le Cessie S, Locati E, Robinson JL, Hall WJ, Andrews ML: Risk of cardiac events in long QT syndrome family members. J Am Coll Cardiol 1995;26:1685-1691.
6. Schwartz PJ, Locati E: The idiopathic long QT syndrome. Pathogenetic mechanisms and therapy. Eur Heart J 1985;6(Suppl D):103-114.
7. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML: Effectiveness and limitations of beta-blocker therapy in congenital long QT syndrome. Circulation 2000;101:616-623.
8. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL: Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation 1991;84:1524-1529.
9. Dorostkar PC, Eldat M, Belhassen B, Scheinman MM: Long-term follow-up of patients with long QT syndrome treated with beta-blockers and continuous pacing Circulation 1999;100:2431-2436.
10. Breithardt G, Wichter T, Haverkamp W, Borggrefe M, Block M, Hammel D, Scheld HH: Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994;127:1151-1158.
11. Silka MJ, Kron J, Dunningan A, Dick M: Sudden cardiac death and the use of Implantable cardioverter-defibrillators in pediatric patients. Circulation 1993;87:800-807.
12. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J: Use of implantable cardioverter defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;78:703-706.
13. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-373.
14. Zareba W, Moss AJ: Long QT syndrome in children. J Electrocardiol 2001;34(Suppl):167-171.
15. Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Benhorin J, Priori SG, Napolitano C, Towbin JA, Keating MT, Robinson JL, Andrews M, Timothy K, Hall WJ: Age and gender-related differences in cardiac events in patients with congenital long QT syndrome. Findings from the International LQTS Registry. Circulation 1998;97:2237-2244.
16. Wilson WR, Greer GE, Grubb BP: Implantable cardioverter-defibrillators in children: A single-institutional experience. Ann Thorac Surg 1998;65:775-778.
17. Saxon LA, Shannon K, Wetzel GT, Endler LK, Klitzner TS: Familial long QT syndrome: electrical storm and implantable cardioverter device therapy. Am Heart J 1996;131:1037-1039.
18. Perry GY, Kosar EM: Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: A report of two cases. Pacing Clin Electrophysiol 1996;19:863-867.
19. Brugada J, Brugada R, Brugada P: Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death J Electrocardiol 2000;33(Suppl):41-47.
20. Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L, Fonteyne W: Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001;85:53-56.
21. Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z: Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002;105:794-799.